Michael Bishop
Analyst · Jefferies
Thank you, Jason. Today I will walk through our third quarter fiscal 2026 financial results, which demonstrate our robust capital position alongside a transitional period for our top-line revenue. Total revenue for the third quarter of fiscal 2026 was $33 million, a 29% decline compared to $46.7 million in the third quarter of fiscal 2025. Breaking this total down, product revenue was $18 million, down from $26 million in the prior year quarter. This reflects fewer module deliveries to South Korea as we completed the repowering of Gyeonggi Green Energy fuel cell park, delivering all 42 modules committed under that program since 2024. Service revenue was $2.4 million compared to $3.1 million a year ago. Generation revenue was $8.8 million, down from $12.4 million, driven principally by lower output from plants in our generation portfolio, including our 7.4-megawatt Groton project, which was out of service for the full quarter pending a planned upgrade that we expect to complete in fiscal 2027. Finally, advanced technology contract revenue was $3.8 million compared to $5.3 million in the third quarter of fiscal 2025. We recorded a gross loss of $24.5 million in the third quarter of fiscal 2026 compared to a gross loss of $5.1 million in the third quarter of fiscal 2025. The primary driver was $17 million of charges recorded during the quarter, consisting of approximately $4 million to reduce the carrying value of certain inventories to net realizable value, and approximately $13 million for losses on firm purchase commitments. Both were recorded in connection with Phase 0 of our capital equipment purchase agreement, or CEPA, with Fit Energy due to the fact that our current product costs and manufacturing overhead exceed the contractual pricing established under that agreement. We operated at an annualized production rate of approximately 37 megawatts during the quarter, which remains below the volume at which we expect our cost structure to align with market-based pricing for orders of this scale. These charges are expected to be limited to identified inventory and purchase commitments for Phase 0 and do not reflect our expectations regarding the overall economic value of the agreement. The loss from operations was $46.7 million, a 51% decrease compared to an operating loss of $95.4 million in the third quarter of fiscal 2025. That improvement was primarily driven by the absence of the asset impairment and restructuring charges that heavily impacted the prior year period. Net loss for the quarter was $45.3 million compared to $91.9 million in the comparable prior year period, and net loss attributable to common stockholders was $45.3 million, or $0.64 per share, compared to $92.5 million, or $3.78 per share, in the prior year quarter. Per share improvement also reflects a higher weighted average share count of 70.4 million shares following our equity issuances over the past 12 months. On a non-GAAP basis, adjusted EBITDA was negative $36.7 million compared to negative $16.4 million in the third quarter of fiscal 2025. That variance was primarily driven by Phase 0 charges I just described, which are not added back in our adjusted EBITDA reconciliation, rather than by any structural degradation in our core operating model. Turning to our commercial progress, we are encouraged by the substantial expansion and evolution of our backlog. As of July 31, 2026, total committed and awarded capacity backlog was $3.6 billion, a significant step change. We have structured our commercial backlog into 2 distinct categories to give investors clear visibility: committed backlog and awarded capacity backlog. Committed backlog, which represents definitive non-cancellable agreements executed by the company and its customers, was $1.3 billion, up approximately 4.1% year-over-year. Awarded capacity backlog was $2.4 billion. Awarded capacity backlog represents commercial awards and capacity reservations where we have been selected as the supplier and the parties are advancing towards execution of definitive agreements. For the third quarter, this category is driven by the 350 megawatts across Phases 1, 2, and 3 of our CEPA with Fit Energy, which was executed in June and provides for up to 380 megawatts in total product, commissioning, and service agreements, including the committed 30-megawatt Phase 0. Fit Energy may elect to proceed with Phases 1, 2, and 3 at its sole option, and no payment obligation arises with respect to a phase until Fit Energy makes an election to proceed with that phase. I want to be clear that awarded capacity backlog is not contracted firm order backlog or a guarantee of future revenue. Amounts may not convert to committed backlog or to revenue in whole or in part, and the timing and amount of any conversion may differ materially from our current estimates. We continue to maintain tight fiscal controls across the company. As summarized on slide 19 of the presentation, total operating expenses for the third quarter of fiscal 2026 were $22.2 million compared to $90.2 million in the third quarter of fiscal 2025. Looking at the details, administrative and selling expenses were $13.6 million for the quarter. Research and development expenses were $8.5 million for the quarter as we continue to invest in key product initiatives to support growth of data center opportunities. This year-over-year reduction in operating expenses was primarily driven by the absence of $68.5 million of asset impairment and restructuring charges incurred during the third quarter of fiscal 2025. Excluding those 1-time historical charges, recurring operating expenses were essentially flat year-over-year with a modest reinvestment in research and development offsetting lower administrative and selling costs. Now turning to the balance sheet and liquidity discussed on slide 21. We ended the quarter with the strongest cash position in our history. Total cash, cash equivalents, and restricted cash as of July 31, 2026, was $737.3 million, up from $440.9 million at April 30, 2026, the end of the prior quarter. Unrestricted cash and cash equivalents represented $658.1 million of that total, with the remaining $79.2 million in restricted cash and cash equivalents pledged as collateral for performance security and letters of credit. Our capital structure also remains straightforward. We carry no corporate convertible or high-yield debt, and our $153.6 million of total debt and finance obligations primarily consist of project-level financing, Export-Import Bank working capital facilities supported by our Korean deliveries, and sale-leaseback obligations. This substantial capital buffer means that our manufacturing capacity expansion at our Torrington, Connecticut, facility is fully funded. We estimate the total requirement to expand Torrington to 500 megawatts of annualized production capacity to be between $200 million and $275 million with completion targeted for June 2028. The expansion is backed by approximately $298 million of net proceeds raised from sales of common stock during the quarter, consisting of $245.5 million from our July underwritten offering and $52.9 million under our open market sale agreement. Looking ahead, we believe our strength in balance sheet and backlog expansion have established a clear path toward mid-term profitability. We are now targeting achieving positive adjusted EBITDA results in the fourth quarter of fiscal year 2027. We believe this target is supported by a series of operational and commercial catalysts. First, we have begun to increase our annualized production rate with the goal of achieving targeted annualized production rate of 100 megawatts in October 2026, up from approximately 37 megawatts this quarter, which should drive operating leverage over time. Beyond that, reaching our adjusted EBITDA target will depend on several key factors, including conversion of our awarded capacity backlog into definitive revenue-generating committed contracts, alignment with customer delivery schedules, and continued execution of our manufacturing cost reduction initiative, as we benefit from higher procurement volumes. There can be no assurance that we will achieve these production rates, the conversion of awarded capacity backlog or the anticipated cost reductions within the timeframe currently expected. In closing, we are executing our strategy with financial discipline, a fully funded manufacturing capacity expansion plan, and a sales pipeline that has grown to approximately 10 gigawatts in fiscal 2026 proposals, which we believe positions us to drive long-term value for our shareholders. Thank you for your continued support, and I will now hand the call back to the operator to open the line for Q&A.